Literature DB >> 3139613

Comparative study on antagonistic effects of low pH and cation supplementation on in-vitro activity of quinolones and aminoglycosides against Pseudomonas aeruginosa.

J Blaser1, R Lüthy.   

Abstract

The antagonistic effects of physiological levels of Ca++ and Mg++ on the in-vitro activity of aminoglycosides and quinolones against Pseudomonas aeruginosa were studied at both pH 7.4 and 5.5. Adding Mg++ and Ca++ (100 mg/l) to commercial media deficient of these cations increased the MICs and MBCs of ciprofloxacin and enoxacin four-fold (2 P less than 0.01), which was significantly less than the 16-fold increase found for gentamicin and netilmicin (2 P less than 0.01). However, the activity of both aminoglycosides and quinolones was similarly affected by reducing the pH to 5.5 (giving eight-fold increases in MICs) or by the combination of both low pH plus cation supplementation (giving 16-fold increases in MICs). These data raise the question whether antagonizing factors should be considered not only for aminoglycosides, but also for quinolones during routine susceptibility tests on P. aeruginosa.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3139613     DOI: 10.1093/jac/22.1.15

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  11 in total

1.  In vitro activity of tosufloxacin, a new quinolone, against respiratory pathogens derived from cystic fibrosis sputum.

Authors:  A G Arguedas; J C Akaniro; H R Stutman; M I Marks
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

2.  Resistance to pefloxacin in Pseudomonas aeruginosa.

Authors:  M Michea-Hamzehpour; C Lucain; J C Pechere
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

Review 3.  Aminoglycoside therapy. Current use and future prospects.

Authors:  R Janknegt
Journal:  Pharm Weekbl Sci       Date:  1990-06-22

4.  Effect of pathological changes of pH, pO2 and pCO2 on the activity of antimicrobial agents in vitro.

Authors:  C König; H P Simmen; J Blaser
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-07       Impact factor: 3.267

5.  N-acetylcysteine selectively antagonizes the activity of imipenem in Pseudomonas aeruginosa by an OprD-mediated mechanism.

Authors:  Jerónimo Rodríguez-Beltrán; Gabriel Cabot; Estela Ynés Valencia; Coloma Costas; German Bou; Antonio Oliver; Jesús Blázquez
Journal:  Antimicrob Agents Chemother       Date:  2015-03-23       Impact factor: 5.191

6.  Effect of peritoneal fluid pH on outcome of aminoglycoside treatment of intraabdominal infections.

Authors:  H P Simmen; H Battaglia; T Kossmann; J Blaser
Journal:  World J Surg       Date:  1993 May-Jun       Impact factor: 3.352

Review 7.  Absorption interactions with fluoroquinolones. 1995 update.

Authors:  B M Lomaestro; G R Bailie
Journal:  Drug Saf       Date:  1995-05       Impact factor: 5.606

8.  Roles of divalent cations and pH in mechanism of action of nitroxoline against Escherichia coli strains.

Authors:  C Pelletier; P Prognon; P Bourlioux
Journal:  Antimicrob Agents Chemother       Date:  1995-03       Impact factor: 5.191

9.  Activity of Moxifloxacin against Mycobacterium tuberculosis in Acid Phase and Nonreplicative-Persister Phenotype Phase in a Hollow-Fiber Infection Model.

Authors:  Arnold Louie; Brandon Duncanson; Jenny Myrick; Michael Maynard; Jocelyn Nole; David Brown; Stephan Schmidt; Michael Neely; C A Scanga; Charles Peloquin; G L Drusano
Journal:  Antimicrob Agents Chemother       Date:  2018-11-26       Impact factor: 5.191

10.  In vitro activity of daptomycin against Enterococcus faecalis under various conditions of growth-phases, inoculum and pH.

Authors:  Xavier Argemi; Yves Hansmann; Daniel Christmann; Sophie Lefebvre; Benoit Jaulhac; François Jehl
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.